The product (pharmaceutical composition) is the subject of the notification,which may be in the form of a spray or a dry xylith, with dry xylitol containing xylitol in the range of 4 g to 30 g, NaHCO3 sodium hydrocarbon in the range of 0,01 g to 2,50 g, NaCl sodium chloride in the range of 0,01 g to 1,20 g, KCl potassium chloride in the range of 0,01 g to 0, 60 g weight in relation to the total mass of the composition, which is variable according to the given dry mass formulation, from 0 to 4,80 g calcium dobesylate, flavouring additives and after dissolving in water allows us to obtain a solution of weight usually up to 240 g, while in the form of a spray it contains xylitol in the range of 1,6% to 12%,NaHCO3 sodium hydrocarbon in the range of 0,01% to 2,5%,NaCl sodium chloride ranging from 0,01% to 1,2%,potassium chloride KCl in the range of 0,01% to 0,6%,Calcium hexahydrate CaCl2 x 6H2O in the range of 0,01% to 0,5%,from 0 to 2% calcium dobesylate and thickeners selected from substances such as xanthine gum, caragen (-? Yeah.-k, -(-) Yeah.ethylcellulose, hydroxyethylcellulose, hydroxypropyl methylcellulose, polyvinylpyrrolidone, polyvinyl alcohol, carboxymethylcellulose, carbomer, hyaluronic acid, hypromellose and preservatives selected from such substances as: benzalkonium chloride, alcohol, chlorobutanol, nipagin M, nipagin P, chlorhexine, thiomersal, Potassium sorbate, bronopolis, flavouring additives, and after completing the composition with water, a solution of 100-g weight is obtained.Przedmiotem zgłoszenia jest preparat (kompozycja farmaceutyczna), który może być w postaci sprayu lub ksylitom postaci suchej, przy czym ksylitom postaci suchej zawiera ksylitol w zakresie od 4 g do 30 g, wodorowęglan sodu NaHCO3 w zakresie od 0,01 g do 2,50 g, chlorek sodu NaCl w zakresie od 0,01 g do 1,20 g, chlorek potasu KCl w zakresie od 0,01 g do 0,60 g wagowych w stosunku do całkowitej masy kompozycji, która jest zmienna w zależności od danej fomulacji suchej masy, od
